Ildong Holdings Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 3.06%

Ildong Holdings Co Ltd (000230) has an Asset Resilience Ratio of 3.06% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000230 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩24.23 Billion
≈ $16.42 Million USD Cash + Short-term Investments

Total Assets

₩793.19 Billion
≈ $537.53 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1999–2025)

This chart shows how Ildong Holdings Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 000230 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Ildong Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Ildong Holdings Co Ltd (000230) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩24.23 Billion 3.06%
Total Liquid Assets ₩24.23 Billion 3.06%

Asset Resilience Insights

  • Limited Liquidity: Ildong Holdings Co Ltd maintains only 3.06% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Ildong Holdings Co Ltd Industry Peers by Asset Resilience Ratio

Compare Ildong Holdings Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for Ildong Holdings Co Ltd (1999–2025)

The table below shows the annual Asset Resilience Ratio data for Ildong Holdings Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.15% ₩1.20 Billion
≈ $814.19K
₩802.86 Billion
≈ $544.09 Million
-1.64pp
2024-12-31 1.79% ₩15.28 Billion
≈ $10.35 Million
₩854.70 Billion
≈ $579.22 Million
-1.78pp
2023-12-31 3.57% ₩31.29 Billion
≈ $21.21 Million
₩877.00 Billion
≈ $594.33 Million
-0.77pp
2022-12-31 4.34% ₩37.42 Billion
≈ $25.36 Million
₩862.55 Billion
≈ $584.54 Million
+1.49pp
2021-12-31 2.84% ₩26.19 Billion
≈ $17.75 Million
₩920.76 Billion
≈ $623.99 Million
+2.21pp
2020-12-31 0.64% ₩5.09 Billion
≈ $3.45 Million
₩799.40 Billion
≈ $541.74 Million
+0.23pp
2019-12-31 0.41% ₩3.30 Billion
≈ $2.23 Million
₩805.63 Billion
≈ $545.96 Million
-1.28pp
2018-12-31 1.69% ₩4.49 Billion
≈ $3.04 Million
₩265.47 Billion
≈ $179.90 Million
+0.75pp
2017-12-31 0.94% ₩2.59 Billion
≈ $1.76 Million
₩274.84 Billion
≈ $186.25 Million
-1.55pp
2016-12-31 2.49% ₩5.09 Billion
≈ $3.45 Million
₩204.09 Billion
≈ $138.31 Million
+1.93pp
2015-12-31 0.56% ₩3.98 Billion
≈ $2.69 Million
₩705.64 Billion
≈ $478.20 Million
+0.16pp
2014-12-31 0.40% ₩2.48 Billion
≈ $1.68 Million
₩620.35 Billion
≈ $420.40 Million
-0.03pp
2013-12-31 0.43% ₩2.68 Billion
≈ $1.82 Million
₩628.21 Billion
≈ $425.73 Million
-0.19pp
2012-12-31 0.62% ₩3.35 Billion
≈ $2.27 Million
₩541.71 Billion
≈ $367.11 Million
-0.43pp
2011-12-31 1.05% ₩5.35 Billion
≈ $3.63 Million
₩511.65 Billion
≈ $346.74 Million
-2.64pp
2010-12-31 3.68% ₩19.57 Billion
≈ $13.27 Million
₩531.23 Billion
≈ $360.01 Million
+2.68pp
2009-12-31 1.00% ₩4.96 Billion
≈ $3.36 Million
₩495.53 Billion
≈ $335.82 Million
-0.34pp
2008-12-31 1.34% ₩5.43 Billion
≈ $3.68 Million
₩404.79 Billion
≈ $274.32 Million
+0.48pp
2007-12-31 0.86% ₩2.90 Billion
≈ $1.96 Million
₩336.03 Billion
≈ $227.73 Million
-0.07pp
2006-12-31 0.93% ₩2.64 Billion
≈ $1.79 Million
₩283.77 Billion
≈ $192.31 Million
+0.57pp
2005-12-31 0.36% ₩941.26 Million
≈ $637.88K
₩258.07 Billion
≈ $174.89 Million
-0.09pp
2004-12-31 0.45% ₩1.05 Billion
≈ $709.94K
₩232.19 Billion
≈ $157.35 Million
-0.30pp
2003-12-31 0.75% ₩1.65 Billion
≈ $1.12 Million
₩218.82 Billion
≈ $148.29 Million
+0.20pp
2002-12-31 0.56% ₩1.09 Billion
≈ $741.62K
₩195.90 Billion
≈ $132.76 Million
-0.14pp
2001-12-31 0.70% ₩1.27 Billion
≈ $863.51K
₩183.11 Billion
≈ $124.09 Million
-0.21pp
2000-12-31 0.91% ₩1.70 Billion
≈ $1.15 Million
₩187.75 Billion
≈ $127.23 Million
+0.78pp
1999-12-31 0.12% ₩234.02 Million
≈ $158.59K
₩188.81 Billion
≈ $127.96 Million
--
pp = percentage points

About Ildong Holdings Co Ltd

KO:000230 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$47.00 Million
₩69.36 Billion KRW
Market Cap Rank
#22213 Global
#1395 in Korea
Share Price
₩6010.00
Change (1 day)
+1.01%
52-Week Range
₩5660.00 - ₩15810.00
All Time High
₩51720.73
About

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more